Authors/Disclosures
|
Leonard L. Yeo, MBBS
(NUHS)
|
The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for stryker. Dr. Yeo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for NUHS. Dr. Yeo has received stock or an ownership interest from cereflo. The institution of Dr. Yeo has received research support from NMRC. |
|
Prakash R. Paliwal, MD
|
No disclosure on file |
|
Ben Wakerley, MD
(Gloucestershire Royal Hospital)
|
No disclosure on file |
|
Aftab Ahmad, MD
(Jurong Health Services Singapore)
|
Dr. Ahmad has nothing to disclose. |
|
Wei Ping Kay Ng, MD
(National University Hospital)
|
Dr. Ng has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. |
|
Loh Pei Kee, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Philippe Ryvlin, MD, PhD
(Unit 301)
|
Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle/Angelini. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini pharma. The institution of Dr. Ryvlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB pharma. The institution of Dr. Ryvlin has received research support from Swiss National Fund. The institution of Dr. Ryvlin has received research support from European Commission (Horizon Europe). |
|
Vijay Sharma
|
No disclosure on file |